http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57193484-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01156aa8ec92c4b855de0734b6b32407
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
filingDate 1981-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cf9d96bab23f219c0f12c7bdea2640c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b93676cdcec9e289b4210d9210327d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f081e0cd986057ed0fb83b1bb1ce5ac
publicationDate 1982-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57193484-A
titleOfInvention Preparation of rifampicin
abstract PURPOSE: To prepare the titled compound useful as a remedy for tuberculosis, in high yield and purity, by reacting rifamycin S with an oxacyclohexane derivative in the presence of an organic acid, and reacting the product with 1-amino- 4-methyl-piperazine. n CONSTITUTION: Rifamycin S is made to react with 1,3-di-alkyl-1,3-diaza-5-oxacyclohexane of formula (R is alkyl) in a solvent such as dimethylformamide in the presence of an organic acid such as acetic acid, oxalic acid, etc., and the reaction product is made to react with 1-amino-4-methylpiperazine at 50W55°C to obtain the objective compound. In the above process, the production of by-products can be suppressed, the rate of reaction is improved and the yield is increased by keeping the pH of the reaction liquid at 5.5W6.8. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1981-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136122621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135925261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70542923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226742448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226742447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236434794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424578775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426107020

Total number of triples: 35.